{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T15:49:36Z","timestamp":1722872976351},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.patbio.2008.05.001","type":"journal-article","created":{"date-parts":[[2008,7,11]],"date-time":"2008-07-11T10:50:15Z","timestamp":1215773415000},"page":"470-476","source":"Crossref","is-referenced-by-count":14,"title":["The dihydrouracil\/uracil ratio in plasma, clinical and genetic analysis for screening of dihydropyrimidine dehydrogenase deficiency in colorectal cancer patients treated with 5-fluorouracil"],"prefix":"10.1016","volume":"57","author":[{"given":"R.","family":"Ben Fredj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ben Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Saguem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2008.05.001_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejca.2006.09.017","article-title":"Increased dihydropyrimidine dehydrogenase activity associated with mild toxicity in patients treated with 5-fluorouracil and leucovorin","volume":"43","author":"Van Kuilenburg","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.patbio.2008.05.001_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","article-title":"Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil","volume":"40","author":"Van Kuilenburg","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.patbio.2008.05.001_bib3","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.patbio.2008.05.001_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjc.6690098","article-title":"Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity","volume":"79","author":"Milano","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.patbio.2008.05.001_bib5","first-page":"4705","article-title":"Clinical implication of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil- associated toxicity: identification of new mutation in the DPD gene","volume":"6","author":"Van Kuilenburg","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.patbio.2008.05.001_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2571(00)00011-X","article-title":"Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil","volume":"41","author":"Johnson","year":"2001","journal-title":"Adv Enzyme Regul"},{"key":"10.1016\/j.patbio.2008.05.001_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejca.2007.01.030","article-title":"Should DPD analysis be required prior to prescribing fluoropyrimidines?","volume":"43","author":"Jane","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.patbio.2008.05.001_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-4347(97)00253-3","article-title":"Semi automated radioassay for determination of dihydropyrimidine dehydrogenase (DPD) activity. Screening cancer patients for DPD deficiency, a condition associated with 5-fluoruracil toxicity","volume":"696","author":"Johnson","year":"1997","journal-title":"J Chromatogr"},{"key":"10.1016\/j.patbio.2008.05.001_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/15257770600894576","article-title":"Activity of pyrimidine degradation enzyme in normal tissues","volume":"25","author":"Van Kuilenburg","year":"2006","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.patbio.2008.05.001_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinbiochem.2006.07.012","article-title":"Identification of a novel mutation in the dihydropyrimidine dehydrogenase gene in a patient with a lethal outcome following 5-fluorouracil administration and the determination of its frequency in a population of 500 patients with colorectal carcinoma","volume":"40","author":"Morel","year":"2007","journal-title":"Clin Biochem"},{"key":"10.1016\/j.patbio.2008.05.001_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.10599","article-title":"Increased risk of grade IV neutropenia after administration of 5-fluorouracil due to dihydropyrimidine dehydrogenase deficiency: high prevalence of the IVS 14+1>A mutation","volume":"101","author":"Van Kuilenburg","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.patbio.2008.05.001_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00008711","article-title":"Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency","volume":"104","author":"Van Kuilenburg","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.patbio.2008.05.001_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI118830","article-title":"Molecular basis of the human dihydropyrimidine dehydropyrimidine deficiency and 5-Fluorouracil toxicity","volume":"3","author":"Wei","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.patbio.2008.05.001_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.1999.17.4.1105","article-title":"Correlation between uracil and dihydrouracile plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancers: a potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage","volume":"17","author":"Gamelin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.patbio.2008.05.001_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.bjp.0705651","article-title":"Circadian rhythm of dihydrouracil\/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels","volume":"141","author":"Jiang","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.patbio.2008.05.001_bib16","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1080\/10826079708000481","article-title":"A simple chromatographic method for the analysis of pyrimidines and their dihydrogenated metabolites","volume":"20","author":"Gamelin","year":"1997","journal-title":"J Liq Chromatogr Related Technol"},{"key":"10.1016\/j.patbio.2008.05.001_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jchromb.2006.02.046","article-title":"High-performance liquid chromatography assay with UV detection for measurement of dihydrouracil\/uracil ratio in plasma","volume":"834","author":"Deporte","year":"2006","journal-title":"J Chromatogr B"},{"key":"10.1016\/j.patbio.2008.05.001_bib18","first-page":"325","article-title":"High- throughput genotyping by DHPLC of the dihydropyrimidine dehydrogenase gene implicated in (fluoro) pyrimidine catabolism","volume":"22","author":"Gross","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.patbio.2008.05.001_bib19","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinchem\/45.8.1133","article-title":"Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis","volume":"45","author":"Jones","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.patbio.2008.05.001_bib20","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1158\/1078-0432.CCR-05-0769","article-title":"Screening for dihydropyrimidine dehydrogenase deficiency","volume":"11","author":"Grem","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.patbio.2008.05.001_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2006.09.006","article-title":"5-fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency","volume":"249","author":"Boisdron-Celle","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.patbio.2008.05.001_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.patbio.2004.12.031","article-title":"Dihydropyrimidine d\u00e9shydrog\u00e9nase (DPD)\u00a0: rythme et cons\u00e9quences","volume":"53","author":"Barrat Petit","year":"2005","journal-title":"Pathol Biol"},{"key":"10.1016\/j.patbio.2008.05.001_bib23","first-page":"337","article-title":"Suppression of the DPYD expression in RKO cells via DNA methylation in the regulatory region of the promoter: a potentially important epigenetic mechanism regulating DPYD expression","volume":"85","author":"Zhang","year":"2007","journal-title":"Cell Biol"},{"key":"10.1016\/j.patbio.2008.05.001_bib24","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1349-7006.2002.tb01243.x","article-title":"Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR","volume":"93","author":"Fujiwara","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.patbio.2008.05.001_bib25","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1158\/1078-0432.CCR-04-0337","article-title":"Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells","volume":"10","author":"Noguchi","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.patbio.2008.05.001_bib26","first-page":"247","article-title":"The role of Sp1 and Sp3 in the constitutive DPYD gene expression","volume":"1756","author":"Zhang","year":"2006","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/j.patbio.2008.05.001_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00280-005-0139-8","article-title":"Toxic death case after capecitabine+oxaliplatine (Xelox) administration: probable implication of dehydropyrimidine dehydrogenase deficiency","volume":"58","author":"Ciccolini","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.patbio.2008.05.001_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.crvi.2007.08.003","article-title":"Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population","volume":"330","author":"Ben Fredj","year":"2007","journal-title":"C R Biol"},{"key":"10.1016\/j.patbio.2008.05.001_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1998.00751.x","article-title":"Dihydropyrimidine dehydrogenase in Caucasians subjects","volume":"46","author":"Ridge","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.patbio.2008.05.001_bib30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00008571-200203000-00007","article-title":"A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphisms","volume":"12","author":"Mattison","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.patbio.2008.05.001_bib31","first-page":"9","article-title":"Dihydropyrimidine dehydrogenase (DPD) deficiency: a 5-fluorouracil-associated pharmacogenomic syndrome","volume":"4","author":"Diasio","year":"2003","journal-title":"Horiz Cancer Ther"},{"key":"10.1016\/j.patbio.2008.05.001_bib32","first-page":"768","article-title":"Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotype","volume":"8","author":"Johnson","year":"2002","journal-title":"Clin Cancer Res"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408001430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408001430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T00:07:26Z","timestamp":1588810046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811408001430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0369811408001430"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2008.05.001","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}